[{"AccountsPayableCurrent_0_Q2_USD":1832000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q2_USD":117000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":193000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":3000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2029000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2129000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3959000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-758000.0,"ShortTermInvestments_0_Q2_USD":133142000.0,"PrepaidInsurance_0_Q2_USD":1210000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":369000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":69000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2130000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":117000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-36204000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-17062000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":3057000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":9809000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":7134000.0,"InvestmentIncomeInterest_2_Q2_USD":558000.0,"InvestmentIncomeInterest_1_Q2_USD":225000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":8691000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-32181000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-16993000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":675294000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1353000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":710000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_1_Q2_USD":85000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":17000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":379000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":758000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":115000.0,"ProceedsFromStockPlans_2_Q2_USD":149000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":33460000.0,"ProceedsFromDebtNetOfIssuanceCosts_2_Q2_USD":19730000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":131125000.0,"PaidInKindInterest_2_Q2_USD":166000.0,"OtherNoncashIncomeExpense_2_Q2_USD":1000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":502000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":240000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":135000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":427000.0,"LongTermLoansPayable_0_Q2_USD":19896000.0,"InterestReceivableCurrent_0_Q2_USD":222000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-1736000.0,"DepositsAssetsCurrent_0_Q2_USD":2968000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":12375000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":1517000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":29002000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":53726000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":133142000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":133024000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"Supplies_0_Q2_USD":147000.0,"OtherAssetsNoncurrent_0_Q2_USD":82000.0,"NonoperatingIncomeExpense_1_Q2_USD":-452000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":237000.0,"ProfitLoss_2_Q2_USD":-32298000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4939000.0,"NetIncomeLoss_1_Q2_USD":-17062000.0,"NetIncomeLoss_2_Q2_USD":-32298000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-37332000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-97665000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":163999000.0,"LiabilitiesNoncurrent_0_Q2_USD":32514000.0,"LiabilitiesCurrent_0_Q2_USD":12467000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":192628000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-527768000.0,"Liabilities_0_Q2_USD":44981000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-4346000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":11963000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6046000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.42,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.97,"CommonStockValue_0_Q2_USD":4000.0,"CommonStockSharesOutstanding_0_Q2_shares":38512744.0,"CommonStockSharesIssued_0_Q2_shares":38512744.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":53611000.0,"AssetsCurrent_0_Q2_USD":191807000.0,"Assets_0_Q2_USD":192628000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2384000.0,"NonoperatingIncomeExpense_2_Q2_USD":-588000.0,"StockholdersEquity_0_Q2_USD":147647000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":40609205.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-59000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-39000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":295000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1015000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":141490.0,"StockIssuedDuringPeriodSharesNewIssues_0_Q2_shares":2095039.0,"ShareBasedCompensation_2_Q2_USD":3959000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":20505000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":10943000.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":37468922.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"OperatingIncomeLoss_2_Q2_USD":-31710000.0,"OperatingIncomeLoss_1_Q2_USD":-16610000.0,"OperatingExpenses_2_Q2_USD":32468000.0,"OperatingExpenses_1_Q2_USD":16989000.0,"InterestPaidNet_2_Q2_USD":629000.0,"InterestExpense_2_Q2_USD":1087000.0,"InterestExpense_1_Q2_USD":638000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":20000000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommitmentsAndContingencies_0_Q2_USD":null,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"UnamortizedDebtIssuanceExpense_0_Q2_USD":235000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]